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These studies indicate that a large percentage of cells in the tumour had Fc receptors on their surface. The proportion of such cells was increased by reducing the number of cells transplanted, by administering cyclophosphamide to the host, and on occasions by the i.p. injection of C. parvum. It was largely unaffected by the route of tumour cell transplantation or by T cell depletion of the host before transplantation but appeared to decline in older (i.e. larger) tumours. Both phagocytic and non-phagocytic cells had Fc receptors on their surface. The phagocytic population appeared to be affected most by procedures which altered the overall percentage of Fc receptor bearing cells. The Fc receptor bearing tumour cells were separated from those devoid of Fc receptors on the basis of their adherent properties. Upon transplantation to isogeneic hosts both populations gave rise to tumours containing a high percentage of Fc receptor bearing cells. These studies suggest that many of the Fc receptor bearing cells in our tumour are probably infiltrating cells of host origin. Their significance in relation to tumour growth remains to be established. DETAILED studies during the past few years have convincingly demonstrated that normal and malignant lymphoid and reticuloendothelial cells may have on their surface receptors for antigen/antibody complexes and aggregated JgG, the so-called Fc receptors (reviewed by Kerbel and Davies, 1974) . A number of observations also indicate that a significant proportion of the cells in certain nonlymphoreticular tumours may also possess Fc receptors (Milgrom et al., 1968; Cohen, Gurner and Coombs, 1971; Tonder, Morse and Humphrey, 1974; Kerbel and Davies, 1974) . These Fc receptors have been demonstrated by both cryostat haemadsorption techniques (Milgrom et al., 1968; Tonder et al., 1974) and by conventional rosetting procedures with suspensions of tumour cells and antibody coated sheep erythrocytes (Cohen et al., 1971;  Kerbel and Davies, 1974) . The tumours studied included a variety of human adenocarcinomata and epidermoid carcinomata (Tonder et al., 1974) , tumours of murine connective and epithelial tissue (Kerbel and Davies, 1974) and a transmissible venereal tumour in the dog (Cohen et al., 1971) .
With the exception of the studies on the transmissible venereal tumour, the identity of the Fc receptor bearing cells * (Evans, 1972) . However, as stressed by Kerbel and Davies (1974) (MacLennan, 1972 Tumours.-The tumour used was an isogeneic methylcholanthrene induced fibrosarcoma in its 18th transplant generation. Details of the induction and propagation of this tumour are recorded elsewhere (Woodruff and Boak, 1966) . Tumour cell suspensions were prepared from freshly excised tumours by teasing a tumour apart in 5-10 ml of a pronase Dulbecco solution and then incubating the suspension obtained for 5-10 min at 37°C in the same solution. The pronase Dulbecco solution contained 2-5 g of grade B pronase (Calbiochem Ltd, London, England), 5 x 105 u penicillin, 5 mg streptomycin and 0-2 mg neomycin in one litre of Dulbecco balanced salt solution (Oxoid, London, England) adjusted to pH 7-2. A short period of incubation was adopted to avoid possible changes in the tumour cell surface. The cell suspension obtained was washed 3 times in Minimal Essential Medium (MEM) (Gibco-Biocult Glasgow, Scotland) and adjusted to 2 x 106 cells/ml before transplantation or use in the rosette assay. Unless otherwise stated, the cells were transplanted by subcutaneous injection into the right thigh. The growth of the tumour was assessed continuously throughout each experiment by measuring 2 diameters at right angles. At the end of the experiment the mice were killed by ether inhalation or cervical dislocation.
Bacterial organi8ms.-The formalin killed suspension of C. parvum strain no. CN6134 was a gift from the Wellcome Research Laboratories, Beckenham, Kent. Formalin killed suspensions of the other organisms used, namely Propionibacterium freudenreichii strain no. 10470 and C. parvum strain no. 10387, were kindly provided by Dr W. H. McBride of the Department of Bacteriology, University of Edinburgh. They had been prepared as previously described from organisms obtained from the National Collection of Type Cultures, Colindale, England (McBride et al., 1975) . Details of the dose and route of injection of these suspensions is contained in the Tables. For practical reasons, smaller doses of C. parvumn 3'7 were used when it was injected subcutaneously (see Table V ) or immediately adjacent to the site of a tumour (see Table VI ). Unless otherwise stated, strain CN6134 was used throughout these studies.
Rosette technique.-The proportion of Fc receptor bearing cells in tumour cell suspensions was assessed by determining the ability of such cells to form rosettes with antibody coated sheep erythrocytes (SRBC). The rosetting technique was undertaken as follows:
Antiserum for coating the SRBC was produced in CBA mice by injecting them intraperitoneally (i.p.) with 4 x 108 washed SRBC and bleeding them out 10 days later. It was inactivated at 56°C for 30 min before use in the rosette assays. Studies undertaken with Sephadex G-200 fractions of this serum indicated that the maximum number of rosettes was obtained with SRBC sensitized with the 7S fraction (see also Milgrom et al., 1968) . A series of preliminary experiments was also performed to ascertain the optimum conditions for the rosette forming assay. On the basis of the results obtained (see Fig. 1 ) the following procedure was adopted:
Sensitized SRBC (EA-SRBC) were prepared by incubating 1 ml of washed 5% (vol/vol) SRBC with 1 ml of a 100-fold dilution of mouse anti SRBC for 30 min at 3700. The sensitized cells were then washed 3 times and resuspended in 5 ml of the MEM used throughout the sensitization procedure.
The percentage of rosette forming cells in a tumour was determined by mixing 0-25 ml of tumour cell suspension (containing 2 x 106 cells/ml) with 0-25 ml of 1% EA-SRBC. This mixture was then centrifuged for 5 min at 2000 rev/min, after which it was incubated at 370C for 30 min. Following incubation, the cells were carefully resuspended using a Pasteur pipette and the percentage of rosette forming cells determined microscopically by counting at least 200 tumour cells. In all cases the rosette forming tumour cells were readily discernible (see Fig. 2 figure. On the basis of these results the SRBC were sensitized with antibody diluted 100-fold and the rosettes were routinely counted after centrifugation and incubation at 370C for 30 min.
as above, adding 50,u1 of heat inactivated foetal calf serum and incubating for 2 h at 37°C in a shaking water bath. After incubation, the cell mixture was gently resuspended with a Pasteur pipette and 25-50 jul of the suspension was applied to a microscope slide and covered with a glass cover slip. Upon microscopic examination, 3 populations of cells could be readily distinguished, namely, (1) a population of rosette forming cells which did not exhibit phagocytosis (see Fig. 4 ). The latter were designated Fc -ve cells. Preliminary studies indicated that the phagocytic Fe receptor bearing cells could be readily distinguished using SRBC sensitized with a 100-fold dilution of anti-SRBC antibody (see Fig. 5 ). This dilution was therefore used in all subsequent tests. Additional studies also revealed that the number of cells phagocytosing antibody coated SRBC was largely unaffected by suspending the rosetting cells in tris buffered NH4C1, thus confirming that the SRBC were indeed phagocytosed and not simply adherent to the tumour cell surface. Parallel studies also indicated that the cells which phagocytosed antibody coated SRBC also took up colloidal carbon, thus confirming their phagocytic properties. It should also be stressed that the rosette formation observed could be blocked by pretreating the tumour cell suspension with heat aggregated IgG. This treatment is used routinely to block the formation of rosettes between EA-SRBC and B cells or monocytes. In order to compensate for possible variations in the sensitivity and reproductivity of the rosetting technique, untreated tumour bearing control groups were included in every experiment when effects of therapy were being investigated. In addition, with one unavoidable exception (see Table III ) the assays in all groups were always performed in parallel. Cell separation procedures.-Preparations rich in Fe receptor bearing cells were isolated from tumour cell suspensions by the following procedure: Tumour cell suspensions prepared as described earlier were resuspended at a concentration of 2-3 x 106 cells/ml in RPMI 1640 medium (Gibco-Biocult, Glasgow, Scotland) containing 10% (vol/vol) heat inactivated foetal calf serum, 2 mmol/l glutamine, 100 u penicillin/ml and 100 ,ug streptomycin/ml. Four ml of this suspension was poured into a 5 cm tissue culture Petri dish (Product No 302V supplied by Sterilin Ltd, Richmond, Surrey, England).
The dish was sealed with parafilm and incubated for 2 h at 37°C. At the end of this time the non-adherent cells were carefully removed by decantation and the adherent cells gently washed 3 times with RPMI-FCS, the washings being decanted on each occasion. Finally the adherent cells were dislodged from the dish by rubbing with a rubber policeman. Practically all of the adherent cells recovered formed rosettes with EA-SRBC. Tumour cell suspensions deficient in Fc receptor bearing cells were obtained by 2 procedures. The first involved the further processing of the non-adherent cell population removed above. These cells were incubated for a second and third time as described in the preceding paragraph. The non-adherent cell population obtained after the third incubation was totally devoid of Fc receptor bearing cells. The second approach involved culturing tumour cell suspensions in glass bottles for 10 days as previously described by Ghaffar et al. (1974) . These cells were subcultured at least 4 times before harvesting. Table II Table III ).
The influence of bacterial organisms on the Fc receptor bearing cell content of tumours
In view of the observations that C. parvum and other bacterial organisms readily inhibit the growth of the MC 1/1600 fibrosarcoma used in these studies (McBride et al., 1975) (7 7-9.3) (9-5-10-0) 6-0 7-2 (5 6-6.4) (6-4-8-1) 10-7 (9 6-11. 9) [8] [9] (8 2-7 8) 16 Note. On this occasion the administration of C. parvum had no effect on the overall proportion of Fc receptor bearing cells. 56-3±10-0 § (7-9-10-3) C 8
Propionibacterium freudenreichii 35-8±10-3 cells and injected i.p. 3 days later with 1-4 mg of C. parvum. Control mice received tumour alone. These studies suggested (see Table IV ) that the C. parvum protocol used did not exert a dramatic effect upon the Fc receptor bearing cell content of transplanted tumours, at least in their early stages of growth. It did appear, however, to halt the dramatic decline in the Fc positive cell content noted in older tumours, though further experiments with larger numbers of animals will be necessary to establish this point.
An experiment was also performed to see if the effect, if any, of C. parvum on the Fc receptor bearing cell content of tumours was dependent upon the route of administration of C. parvum, as this is known to influence the antitumour effect of this reagent (Woodruff, McBride and Dunbar, 1974; Scott, 1974) . In these experiments mice were challenged with tumour cells on Day 0 and injected s.c. or i.p. with 0 7 mg of C. parvum 3 days later. The animals were killed 23 days after tumour cell transplantation and the total Fc receptor bearing cell content of the tumours determined. It was found that the administration of C. parvum by either the s.c. or the i.p. route failed to influence the total Fc receptor bearing cell content of the tumours (see Table V ). It should also be noted that, as previously observed, the i.p. administration of C. parvum significantly inhibited tumour growth while s.c. administration at a site distant from the tumour was without effect Scott, 1974) .
The effect of local administration of C. parvum was determined by injecting 0 7 mg dry weight of this organism s.c. immediately adjacent to the site of a growing tumour. The C. parvum was injected 8 days after the transplantation s.c. of 1 x 106 viable tumour cells. Previous studies in our laboratory had shown that this C. parvum protocol inhibited the growth of tumour arising following the s.c. transplantation of 1 x 104 4 tumour cells . However, it will be observed that in the present experiment (see Table VI The 2 strains of C. parvum tested significantly inhibited tumour growth and also significantly increased the proportion of Fc receptor bearing cells in the excised tumour. In contrast, the administration of P. freundenreichii failed to inhibit tumour growth or to alter the incidence of Fc receptor bearing cells (see Table  VII ). It should be noted that the effects of P. freundenreichii and C. parvum strain 10387 on tumour growth are somewhat different than previously reported (McBride et al., 1975) . This might, however, be due to differences in the number of tumour cells transplanted and the weight of organisms injected.
The incidence of Fc receptor bearing cells in immunologically deprived and immunosuppressed mice Previous reports from our laboratory have shown that i.p. administered C. parvum exerts an anti-tumour effect in T cell deprived, that is, B mice (Woodruff, Dunbar and Ghaffar, 1973) . In an attempt to further elucidate the mechanism by which C. parvum exerts an antitumour effect in B mice the following experiment was performed:
Mice were thymectomized at the age of 4-6 weeks and one week later they received 850 rad whole body irradiation, followed 8 h later by the i.v. infusion of 4 x 106 anti-O antibody treated isogeneic bone marrow cells. Six weeks after reconstitution the mice were challenged with 1 x 104 tumour cells and after a further interval of 3 days 1*4 mg of C. parvum was injected i.p. Control mice were sham thymectomized, irradiated and reconstituted as above.
The incidence of Fc positive tumour cells was no different in thymectomized mice than in sham thymectomized controls (see Groups A and C, Table VIII ). Furthermore, the percentage of such cells was not significantly affected by the administration of C. parvum even though it significantly inhibited the growth of tumour in the B mice. It will be noted, however, that the proportion of Fc positive cells in all groups was greater than normally observed. Whether or not this is a property of tumours grown in irradiated bone marrow reconstituted mice, or a reflection of the variability of the rosetting procedure, remains to be established.
The effect of immunosuppressive treatment on the Fc receptor bearing cell content of tumours was investigated by treating tumour challenged mice with cyclophosphamide as indicated in Table  IX . This treatment was found to significantly inhibit the growth of transplanted tumour and at the same time significantly increase its proportion of phagocytic Fe receptor bearing cells. The proportion of non-phagocytic Fc positive cells was not significantly affected by cyclophosphamide administration.
Fc receptor bearing cells in tumours grown from Fc deficient and Fc enriched tumour cell suspensions
In these experiments mice were challenged s.c. with tumour cell suspensions deficient or enriched in Fe receptor bearing cells. These suspensions were prepared as described earlier. Both types of preparation gave rise to tumours in which there were cells expressing Fc receptors on their surface (see Table X (Milgrom et al., 1968; Cohen et al., 1971; T0nder et al., 1974; Kerbel and Davies, 1974 . Experiments are in progress to characterize the effector cell in this system and to establish if it is of host origin.
The present studies demonstrate that a number of factors influence the relative proportion of Fc receptor bearing cells in our tumour. For example, it may be increased by transplanting small doses of tumour cells (contrast Evans, 1972) , by the administration of cyclophosphamide and on occasion by the i.p. injection of certain adjuvants. In all these cases it is interesting to note that the procedures used limit the size of the tumour. Conversely, if large tumour doses are transplanted, or the tumour is allowed to grow for a longer time, then the proportion of Fc receptor bearing cells decreases. This is undoubtedly due to a disproportionate increase in the Fc negative population and not to an actual decline in the absolute numbers of Fc receptor bearing cells. These observations suggest that procedures which limit tumour growth are those which favour a high Fc +ve/Fc -ve (and presumably macrophage/tumour) cell ratio. If this is so, then one has to explain the somewhat inconsistent effects of C. parvum for occasionally it exerted an appreciable antitumour effect without increasing the proportion of Fc receptor bearing cells (see Table V ). In addition, Eccles and Alexander (1974) have shown that BCG can exert an anti-tumour effect without significantly increasing the macrophage content of tumours. Nevertheless, it is conceivable that the C. parrurn protocol used in Table V increased the proportion of phagocytic Fc receptor bearing cells and that this population influences tumour growth.
The observation that tumours grown in B mice also have as many Fc receptors on their cell surfaces as appropriate control mice is of interest. As expected, it confirms that these adherent Fc receptor bearing cells are not of T origin or dependent upon T cells for their generation. Furthermore, it also suggests that their localization within tumours is not a consequence of the release of soluble factors (lymphokines) following contact of tumour antigen and T cells. In contrast to our observations others have reported that prior thymectomy and x-irradiation of rats influences the macrophage content of a transplanted syngeneic benzpyrene induced fibrosarcoma, the level being much lower than in sham thymectomized controls (Eccles and Alexander, 1974) . However, in these experiments the thymectomized x-irradiated rats were not repopulated with bone marrow cells as in our studies, and this may have contributed to the difference.
Although these results establish clearly that many of the cells in tumour cell suspensions bear Fc receptors upon their surface and indicate that a large proportion of such cells are phagocytic, the precise significance of these cells in relation to tumour growth remains to be established. Further studies on the proportion of phagocytic and non-phagocytic rosette forming cells in tumours and the effect of various therapeutic procedures thereupon will undoubtedly help elucidate their importance in tumour surveillance. Kerbel, Pross and Elliot (Int. J. Cancer, 1975, 15, 918) recording results similar to our own. These authors demonstrate convincingly that a variety of tumours contain Fc receptor bearing cells, the majority of which are phagocytic. These cells were also lost following culture in vitro and transplantation of the cultured cells also gave rise to tumours containing a high proportion of Fc receptor bearing cells. Cytotoxic studies with anti-H2 sera on tumours transplanted to F1 hybrids indicated that many (if not all) of the Fc receptor bearing cells were of host origin.
